Who Paid My Doc
A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov NCT02521870
Research payments
$3,787,297
Through program year 2021, $3,787,297 in research payments was reported against A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma, across 356 payments, paid by Dynavax Technologies Corporation.
- Paid by
- Dynavax Technologies Corporation
- ClinicalTrials.gov
- NCT02521870
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $93,278 | 22 |
| 2020 | Research | $997,077 | 131 |
| 2019 | Research | $2,696,942 | 203 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Robert Conry Birmingham, AL Named on 25 payments
- Lisle Nabell Birmingham, AL Named on 24 payments
- Amy Weise Detroit, MI Named on 23 payments
- Mohammed Almubarak Morgantown, WV Named on 22 payments
- Gregory Daniels San Diego, CA Named on 19 payments
- Anoosh Montaser Costa Mesa, CA Named on 19 payments
- Theresa Medina Aurora, CO Named on 17 payments
- Christopher Lao Ann Arbor, MI Named on 15 payments
- Alexandra Ikeguchi Oklahoma City, OK Named on 14 payments
- Mohammed Milhem Iowa City, IA Named on 14 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.